ArticlePloS one2025
Epidemiological patterns of SARS-CoV-2 reinfections in Espírito Santo, Brazil: A population-based analysis using integrated surveillance and vaccination data.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundReinfections with SARS-CoV-2 have gained increasing relevance in the context of emerging immune-evasive variants and waning population immunity. Understanding their frequency and distribution is essential to guide public health strategies, particularly in middle-income countries. This study investigates the epidemiological patterns of SARS-CoV-2 reinfections in Espírito Santo, Brazil, using integrated notification and vaccination databases.
methodsWe conducted a retrospective population-based study using state-level surveillance and immunization data from September 2020 to February 2023. Deterministic record linkage was performed to identify reinfections based on four hierarchical definitions, all requiring a minimum 90-day interval between episodes. Reinfection rates were analyzed by demographic, temporal, regional, and vaccination-related variables. Specific contexts such as Indigenous communities and long-term care facilities were also explored.
resultsReinfection estimates varied widely depending on the definition used-from 0.27% under the strictest criteria to 9.72% under the most inclusive. Reinfections were more common among women and adults aged 30-49 years. The highest proportions occurred during the second and fourth waves, driven by the Gamma and Omicron variants, respectively. Reinfection rates were particularly elevated in Indigenous communities (16.5%) and long-term care facilities (14%), highlighting structural vulnerabilities. In contrast, no increased reinfection risk was observed among incarcerated populations, possibly due to data limitations. Reinfections were frequent among vaccinated individuals, especially those who had received two doses without boosters. However, this likely reflects exposure patterns and time since vaccination, rather than reduced vaccine effectiveness. Brazil's use of inactivated-virus vaccines, such as CoronaVac, in the early phases may also have influenced susceptibility. Reinfections occurred predominantly after the emergence of Omicron, consistent with findings from national and global studies.
conclusionsThis study shows that the cumulative frequency of reinfections increased over the study period, reaching up to ~10% under the most inclusive definition, while remaining modest under the strictest criteria. These findings reinforce the importance of continued genomic surveillance, timely booster campaigns, and targeted interventions in high-risk environments. The integration of multiple data sources and the use of variable reinfection definitions allowed for a nuanced analysis, offering valuable insights to inform public health planning in Brazil and similar contexts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.